A new trading day began on Monday, with Generation Bio Co (NASDAQ: GBIO) stock price up 3.62% from the previous day of trading, before settling in for the closing price of $4.06. GBIO’s price has ranged from $0.30 to $3.65 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -8.30%. Meanwhile, its annual earnings per share averaged 44.55%. With a float of $45.82 million, this company’s outstanding shares have now reached $67.01 million.
The extent of productivity of a business whose workforce counts for 115 workers is very important to gauge. In terms of profitability, gross margin is 100.0%, operating margin of -331.33%, and the pretax margin is -292.92%.
Generation Bio Co (GBIO) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Generation Bio Co is 31.65%, while institutional ownership is 54.25%. The most recent insider transaction that took place on Jan 10 ’25, was worth 120,759. In this transaction Director of this company bought 125,791 shares at a rate of $0.96, taking the stock ownership to the 214,286 shares. Before that another transaction happened on Jan 13 ’25, when Company’s Director bought 85,000 for $0.97, making the entire transaction worth $82,450. This insider now owns 299,286 shares in total.
Generation Bio Co (GBIO) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.26 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 44.55% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 22.41% during the next five years compared to -8.30% drop over the previous five years of trading.
Generation Bio Co (NASDAQ: GBIO) Trading Performance Indicators
Here are Generation Bio Co’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 8.43. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 11.49.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.08, a number that is poised to hit -0.28 in the next quarter and is forecasted to reach -1.12 in one year’s time.
Technical Analysis of Generation Bio Co (GBIO)
The latest stats from [Generation Bio Co, GBIO] show that its last 5-days average volume of 3.84 million was superior to 0.75 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 44.44%.
During the past 100 days, Generation Bio Co’s (GBIO) raw stochastic average was set at 37.40%, which indicates a significant decrease from 39.42% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0453 in the past 14 days, which was higher than the 0.0416 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.3846, while its 200-day Moving Average is $0.9287.
